s6y
Company name or ticker
Search
Altamira Therapeutics Ltd.
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Filed
Monday, March 10, 2025
Period
Mar 10, 2025
Accession number
0001213900-25-022236
Documents
REPORT OF FOREIGN PRIVATE ISSUER
6-K
On sec.gov
Filing index
All files
Complete submission text
SGML header